Evidence map›Paper›PMID 35015072›Full record

ArticleThe Biochemical journal2022

Proteomic analysis in primary T cells reveals IL-7 alters T cell receptor thresholding via CYTIP/cytohesin/LFA-1 localisation and activation.

Rayner M L Queiroz, Siân C Piper, Johanna S Rees, Sam Strickson, Emmanuel Briend, Choon Pei Low, G John Ferguson, Kathryn S Lilley, Antony P Jackson, Donna K Finch

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 6 countries.

Rayner M L Queiroz *Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, U.K.
Siân C Piper *Bioscience Asthma, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
Johanna S Rees *Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, U.K.ORCID 0000-0003-2066-8617
Sam StricksonBioscience Asthma, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
Emmanuel BriendBioPharmaceutical R&D, AstraZeneca, Cambridge, U.K.
Choon Pei LowBiologic Therapeutics 3, Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, U.K.
G John FergusonTranslational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
Kathryn S LilleyDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, U.K.
Antony P JacksonDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, U.K.
Donna K FinchBioPharmaceutical R&D, AstraZeneca, Cambridge, U.K.
University of Cambridge · GBAstraZeneca (South Korea) · KRAstraZeneca (Switzerland) · CHAstraZeneca (Finland) · FIAstraZeneca (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of the cellular immune system to discriminate self from foreign antigens depends on the appropriate calibration of the T cell receptor (TCR) signalling threshold. The lymphocyte homeostatic cytokine interleukin 7 (IL-7) is known to affect TCR thresholding, but the molecular mechanism is not fully elucidated. A better understanding of this process is highly relevant in the context of autoimmune disease therapy and cancer immunotherapy. We sought to characterise the early signalling events attributable to IL-7 priming; in particular, the altered phosphorylation of signal transduction proteins and their molecular localisation to the TCR. By integrating high-resolution proximity- phospho-proteomic and imaging approaches using primary T cells, rather than engineered cell lines or an in vitro expanded T cell population, we uncovered transduction events previously not linked to IL-7. We show that IL-7 leads to dephosphorylation of cytohesin interacting protein (CYTIP) at a hitherto undescribed phosphorylation site (pThr280) and alters the co-localisation of cytohesin-1 with the TCR and LFA-1 integrin. These results show that IL-7, acting via CYTIP and cytohesin-1, may impact TCR activation thresholds by enhancing the co-clustering of TCR and LFA-1 integrin.

Indexed as

Actin CytoskeletonBlood DonorsCells, CulturedGuanine Nucleotide Exchange FactorsHumansInterleukin-7Lymphocyte ActivationLymphocyte Function-Associated Antigen-1PhosphorylationProteomeProteomicsReceptors, Antigen, T-CellRecombinant ProteinsSignal TransductionThreonineT-LymphocytesCYTIP protein, humancytohesin-1Guanine Nucleotide Exchange FactorsIL7 protein, humanInterleukin-7Lymphocyte Function-Associated Antigen-1ProteomeReceptors, Antigen, T-CellRecombinant ProteinsThreonineTranscription FactorsCYTIP/cytohesinIL7LFAphosphoproteomicsSPPLATTCR

Identifiers

PMID35015072
PMCPMC8883493
OpenAlexW4206112080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.